Pharma Deals Review, Vol 2002, No 27 (2002)

Font Size:  Small  Medium  Large

Wyeth Licenses Interleukin Receptor Patents from ZymoGenetics

Business Review Editor

Abstract


Wyeth licensed two US patent applications for Interleukin-13 receptor subunit (IL-13R alpha2), also known as WSX-II, from ZymoGenetics. WSX-II is a naturally occurring decoy receptor, capable of binding the cytokine IL-13.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.